Investor Relations Critical Outcome - Investor Update - July 2013

Presentation used to update shareholders of Critical Outcome Technologies on recent developments with the company's drug discovery collaborations and its p53 cancer…

Investor Relations Critical Outcome Technologies - Investor Presentation - June 2013

Critical Outcome Technologies Inc. streamlines drug discovery - dramatically reducing the time and cost to bring new drugs to market. The Company is listed on the TSX Venture…